Alithea Genomics develops molecular biology tools and sequencing-based solutions for large-scale gene expression analysis.
Alithea Genomics has raised $3.8M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
Alithea Genomics's investors include Genku Ventures, Kickfund, Zürcher Kantonal Bank, Novalis Biotechnology Incubation, TechU Ventures.
Alithea Genomics is headquartered in Lausanne, Switzerland.
Alithea Genomics develops molecular biology tools and sequencing-based solutions for large-scale gene expression analysis.
Alithea Genomics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alithea Genomics — Funding & Investors." VCBacked, March 4, 2026, https://www.vcbacked.co/company/alithea-genomics. Accessed September 30, 2026.
VCBacked. (2026). Alithea Genomics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/alithea-genomics
{{cite web |title=Alithea Genomics — Funding & Investors |url=https://www.vcbacked.co/company/alithea-genomics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated